Executive Director, Development Quality

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits.

This is work that transforms the lives of patients, and the careers of those who do it.

The Executive Director, Development Quality reports into VP, R&D Quality and provides strategic and operational quality leadership across all therapeutic areas, overseeing development programs from first-in-human (FIH) through lifecycle management (LCM). As the accountable Quality partner to the Global Drug Development (GDD) and Global Development Operations (GDO), this leader provides oversight of GxP compliance, inspection readiness, and quality culture across a diverse program portfolio.

This is a highly visible leadership role at the intersection of quality, science, and strategy. The ED, Development Quality is expected to be a quality champion who can engage credibly with scientists, medics clinicians, regulatory affairs professionals, and senior executives alike, driving quality not as a compliance function, but as a strategic enabler of patient-centered drug development.

This role partners with RDQ cross-pillar leaders, Global Quality, and R&D stakeholders to drive proactive quality and QMS compliance. Represents RDQ in key governance forums, overseeing the identification, escalation, and mitigation of quality and compliance risks. Serves as the single point of quality accountability across the product lifecycle, partnering with regulatory authorities, senior leadership, and cross-functional teams to embed Quality by Design and risk-based decision-making that enables innovation, speed, and sustainable growth.

Leading with an enterprise-first, transformational mindset, this role continuously evolves the Development Quality organization, simplifying processes, optimizing resources, and driving cross-functional collaboration to deliver measurable quality and compliance outcomes. The leader, where applicable, evolves the Development Quality mission, vision, and strategic roadmap in alignment with R&D Quality, Global Quality and BMS objectives, building future-ready capabilities that accelerate delivery of innovative therapies to patients.

• Define and drive the TA Quality oversight strategy, assuring quality standards are embedded from FIH through LCM across all development programs.

• Drive and oversee Trial Quality Health via Trial Quality Performance Narratives and GCP Consultation.

• Serve as the senior quality business partner to TA leadership, Drug Development, Clinical Operations, Regulatory Affairs, and Medical Affairs, providing proactive quality guidance and risk-based oversight.

• Oversee quality risk assessments and escalation management for high-impact program decisions, regulatory submissions, and post-approval changes.

• Champion a right-first-time quality culture and continuous improvement mindset across the enterprise.

• Partner with GDD/GDO leadership to align TA quality strategies with enterprise-wide quality objectives and standards.

• Lead and/or represent RDQ at key governance bodies, proactively identifying and escalating quality and compliance risks and driving resolution plans (Serious Non-Compliance/Breach Committee, R&D Quality Council, Enterprise Quality Council etc.)

• Ensure inspection readiness through proactive quality oversight, mock…